EP2402004A3
Methods and compositions for deterring abuse of opioid containing dosage forms
Abstract
This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
Term
Term ended
Projected expiry passed 23 November 2024, 1.8 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| EP1293195A1 | Cites | European Patent Office (EPO) | Y | Search report | 1-33 |
| US2003068371A1 | Cites | United States of America | Y | Search report | 1-33 |
| US2003124061A1 | Cites | United States of America | Y | Search report | 1-33 |
| WO2004037259A1 | Cites | World Intellectual Property Organization (WIPO) | XP | Search report | 1-5,7,11-17,20,24-26 |
43 members in 7 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 723654 | United States of America | – | |
| 72365403 | United States of America | A | |
| 72365403 | United States of America | A | |
| 04812083 | European Patent Office (EPO) | A | |
| 04812083 | European Patent Office (EPO) | A | |
| 04812083 | – | – | – |
| 723654 | – | – | – |
| EP20040812083 | – | – | – |
| US20030723654 | – | – | – |
Members43
| Document | Office | Kind | |
|---|---|---|---|
| US2005112067A1 | United States of America | A1 | |
| AU2004294953A1 | Australia | A1 | |
| CA2547334A1 | Canada | A1 | |
| WO2005053587A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1694260A1 | European Patent Office (EPO) | A1 | |
| IL175863D0 | Israel | D0 | |
| US7201920B2 | United States of America | B2 | |
| US2007166234A1 | United States of America | A1 | |
| US2007264327A1 | United States of America | A1 | |
| EP1694260A4 | European Patent Office (EPO) | A4 | |
| US2009004292A1 | United States of America | A1 | |
| US7476402B2 | United States of America | B2 | |
| US7510726B2 | United States of America | B2 | |
| US2009253730A1 | United States of America | A1 | |
| AU2004294953B2 | Australia | B2 | |
| AU2010200979A1 | Australia | A1 | |
| CA2547334C | Canada | C | |
| US2010216829A2 | United States of America | A2 | |
| US7981439B2 | United States of America | B2 | |
| EP2402004A2 | European Patent Office (EPO) | A2 | |
| US8101630B2 | United States of America | B2 | |
| EP2420225A1 | European Patent Office (EPO) | A1 | |
| EP2402004A3This record | European Patent Office (EPO) | A3 | |
| US2012087982A1 | United States of America | A1 | |
| IL175863A | Israel | A | |
| AU2010200979B2 | Australia | B2 | |
| US8409616B2 | United States of America | B2 | |
| US2013171257A1 | United States of America | A1 | |
| AU2013206525A1 | Australia | A1 | |
| US2013289062A1 | United States of America | A1 | |
| US8637540B2 | United States of America | B2 | |
| IL221018A | Israel | A | |
| US8822489B2 | United States of America | B2 | |
| US2014336213A1 | United States of America | A1 | |
| AU2013206525B2 | Australia | B2 | |
| AU2015264950A1 | Australia | A1 | |
| US9492443B2 | United States of America | B2 | |
| US2017049769A1 | United States of America | A1 | |
| EP1694260B1 | European Patent Office (EPO) | B1 | |
| ES2637338T3 | Spain | T3 | |
| AU2017239544A1 | Australia | A1 | |
| US2018028527A1 | United States of America | A1 | |
| US2021077484A1 | United States of America | A1 |
11 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Designated contracting statesAK | AK | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2402004
- Publication, DOCDB
- 2402004
- Publication, EPODOC
- EP2402004
- Application
- 11158284
- Application, DOCDB
- 11158284
- Application, EPODOC
- EP20110158284
Titles3
- German
- Verfahren und Zusammensetzungen zum Verhindern des Missbrauchs von opioidhaltigen Dosierformen
- English
- Methods and compositions for deterring abuse of opioid containing dosage forms
- French
- Procédés et compositions permettant d'empêcher l'abus d'opioïde dans les formes galéniques
Classification
- CPC, 15
- A61K31/485
- A61K9/2009
- A61K9/2027
- A61K9/2031
- A61K9/2866
- A61P25/04
- A61P25/36
- A61K9/2013
- A61K9/2059
- A61K9/2095
- A61K9/2853
- A61K9/2893
- A61K47/32
- A61K47/34
- A61K47/38
- IPC, 2
- A61K9 20
- A61K31 485
Designated states29
- Contracting states, 29
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Poland
- Portugal
and 5 moreShow fewer
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye